arrow
T

Thomas Southworth

University of Manchester
H指数:25
被引数:1,955

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome
2023-04-0114
OAAI